State of Wisconsin Investment Board’s Taysha Gene Therapies TSHA Stock Holding History

State of Wisconsin Investment Board’s Portfolio TSHA Stock Details TSHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Buy	263,332 +150,154	+133%	+$698K	﹤0.01%	1617
2025 Q4	$622K	Buy	113,178 +70,229	+164%	+$341K	﹤0.01%	1850
2025 Q3	$140K	Buy	+42,949	New	+$122K	﹤0.01%	2299
2022 Q4	–	Sell	-86,600	Closed	-$167K	–	2650
2022 Q3	$167K	Sell	86,600 -23,900	-22%	-$86.8K	﹤0.01%	2441
2022 Q2	$411K	Buy	110,500 +7,400	+7%	+$29.4K	﹤0.01%	2176
2022 Q1	$672K	Buy	103,100 +74,300	+258%	+$555K	﹤0.01%	1730
2021 Q4	$336K	Hold	28,800	–	–	﹤0.01%	1865
2021 Q3	$536K	Hold	28,800	–	–	﹤0.01%	1675
2021 Q2	$611K	Buy	+28,800	New	+$664K	﹤0.01%	1626

Other funds holding TSHA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State of Wisconsin Investment Board's TSHA Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Taysha Gene Therapies (TSHA) stake by 133% in Q1 2026, buying an estimated $698K and bringing the position to 263,332 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

State of Wisconsin Investment Board first reported a position in TSHA in Q2 2021 and has held it in 9 quarters since. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

State of Wisconsin Investment Board held 263,332 shares of Taysha Gene Therapies worth $1.18M as of Q1 2026.
State of Wisconsin Investment Board bought 150,154 Taysha Gene Therapies shares in Q1 2026, an estimated $698K.
Taysha Gene Therapies made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1617 holding.
State of Wisconsin Investment Board first reported a position in Taysha Gene Therapies in Q2 2021 and has held it in 9 quarters since.
191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.